ARCHIVES

NCI Plans Trials of Burzynski’s ‘Antineoplaston’; JAMA Report Says No Antitumor Activity In Tests

This article is from The Cancer Letter archive.

Vol. 18 No. 23 | June 5, 1992

Download PDF Visit The Full Archive

Related Articles

Seattle Cancer Care Alliance Marks its 10th Anniversary—January 2011

June 28, 2021

NCAB Urges $2 Tax On Cigarettes To Reduce Smoking

February 12, 1993

In Congress: $135 Million Expected For DOD Breast Cancer Research Program

July 24, 1998

Planned Parenthood May Be Doing Harm By Selling Breast Cancer Screening to Women Under 40

February 10, 2012

NCI, DCT Board Cool Toward AMA, ACOS, VA Role In Clinical Trials

March 3, 1989

Doctor Files Defamation Suit Against Former Patient, But Legal Action Triggers Adverse Events

April 20, 2012